,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1023841,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,942,CD86,https://ctdbase.org/detail.go?type=gene&acc=942,,,942,CD86,10090,Mus musculus (house mouse),2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of CD86 mrna]]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of CD86 mrna],,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
1,1023842,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019,CDK4,9606,Homo sapiens (human),Ursolic acid results in decreased expression of CDK4 protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
2,1023843,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026,CDKN1A,9606,Homo sapiens (human),Ursolic acid results in increased expression of CDKN1A protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
3,1023844,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027,CDKN1B,9606,Homo sapiens (human),Ursolic acid results in increased expression of CDKN1B protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
4,1023845,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3458,IFNG,https://ctdbase.org/detail.go?type=gene&acc=3458,,,3458,IFNG,10090,Mus musculus (house mouse),2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of PPARG protein]]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of TIMP1 protein]|2-chloro-5-nitrobenzanilide promotes the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of TIMP1 protein]]|2-chloro-5-nitrobenzanilide promotes the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of TIMP1 mrna]]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of CD86 mrna]]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of FCGR2B mrna]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP9 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP2 mrna]]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP9 mrna]|2-chloro-5-nitrobenzanilide promotes the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of CHIL3 mrna]]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP9 mrna]]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP2 protein]]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of TIMP1 mrna]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP2 protein]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of FCGR3 mrna]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of ARG1 mrna]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of PPARG protein]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of CD86 mrna]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP2 mrna]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of CHIL3 mrna]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP9 protein]]|[ursolic acid co-treated with IFNG protein co-treated with lipopolysaccharides] results in increased expression of MRC1 mRNA,,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
5,1023846,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),"Ursolic acid inhibits the reaction [[tetradecanoylphorbol acetate co-treated with 9,10-dimethyl-1,2-benzanthracene] results in increased expression of IL6 mrna]|[glucaric acid co-treated with ursolic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with 9,10-dimethyl-1,2-benzanthracene] results in increased expression of IL6 mrna]",,,PMID:23835587,https://www.ncbi.nlm.nih.gov/pubmed/23835587,23835587,,
6,1024007,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3569,IL6,https://ctdbase.org/detail.go?type=gene&acc=3569,,,3569,IL6,10090,Mus musculus (house mouse),Ursolic acid results in decreased expression of IL6 protein,,,PMID:20869956,https://www.ncbi.nlm.nih.gov/pubmed/20869956,20869956,,
7,1024008,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725,JUN,10090,Mus musculus (house mouse),"[glucaric acid co-treated with ursolic acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with 9,10-dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]|ursolic acid inhibits the reaction [[tetradecanoylphorbol acetate co-treated with 9,10-dimethyl-1,2-benzanthracene] results in increased expression of JUN protein]",,,PMID:23835587,https://www.ncbi.nlm.nih.gov/pubmed/23835587,23835587,,
8,1024009,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3725,JUN,https://ctdbase.org/detail.go?type=gene&acc=3725,,,3725,JUN,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of jun]|resveratrol promotes the reaction [ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of jun]]|ursolic acid promotes the reaction [resveratrol inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of JUN]],,,PMID:26100520,https://www.ncbi.nlm.nih.gov/pubmed/26100520,26100520,,
9,1024010,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3952,LEP,https://ctdbase.org/detail.go?type=gene&acc=3952,,,3952,LEP,10090,Mus musculus (house mouse),Ursolic acid results in increased expression of LEP protein,,,PMID:20869956,https://www.ncbi.nlm.nih.gov/pubmed/20869956,20869956,,
10,1024011,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,9361,LONP1,https://ctdbase.org/detail.go?type=gene&acc=9361,,,9361,LONP1,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [ochratoxin A results in decreased expression of LONP1 protein],,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
11,1024012,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5594,MAPK1,https://ctdbase.org/detail.go?type=gene&acc=5594,,,5594,MAPK1,10116,Rattus norvegicus (Norway rat),"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased phosphorylation of MAPK1 protein]]|ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased phosphorylation of MAPK1 protein]",,,PMID:27274199,https://www.ncbi.nlm.nih.gov/pubmed/27274199,27274199,,
12,1024013,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5595,MAPK3,https://ctdbase.org/detail.go?type=gene&acc=5595,,,5595,MAPK3,10116,Rattus norvegicus (Norway rat),"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased phosphorylation of MAPK3 protein]]|ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased phosphorylation of MAPK3 protein]",,,PMID:27274199,https://www.ncbi.nlm.nih.gov/pubmed/27274199,27274199,,
13,1024014,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599,MAPK8,10116,Rattus norvegicus (Norway rat),"Ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased phosphorylation of MAPK8 protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased phosphorylation of MAPK8 protein]]",,,PMID:27274199,https://www.ncbi.nlm.nih.gov/pubmed/27274199,27274199,,
14,1024015,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5601,MAPK9,https://ctdbase.org/detail.go?type=gene&acc=5601,,,5601,MAPK9,10116,Rattus norvegicus (Norway rat),"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased phosphorylation of MAPK9 protein]]|ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased phosphorylation of MAPK9 protein]",,,PMID:27274199,https://www.ncbi.nlm.nih.gov/pubmed/27274199,27274199,,
15,1024153,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313,MMP2,9606,Homo sapiens (human),Ursolic acid results in decreased secretion of and results in decreased activity of and results in decreased expression of MMP2 protein|[ursolic acid co-treated with irinotecan] results in decreased secretion of and results in decreased activity of and results in decreased expression of MMP2 protein|[ursolic acid co-treated with oleanolic acid co-treated with irinotecan] results in decreased secretion of and results in decreased activity of and results in decreased expression of MMP2 protein|[ursolic acid co-treated with oleanolic acid] results in decreased secretion of and results in decreased activity of and results in decreased expression of MMP2 protein,,,PMID:36191607,https://www.ncbi.nlm.nih.gov/pubmed/36191607,36191607,,
16,1024154,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313,MMP2,9606,Homo sapiens (human),Ursolic acid results in decreased expression of MMP2 mRNA,,,PMID:21539908,https://www.ncbi.nlm.nih.gov/pubmed/21539908,21539908,,
17,1024155,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313,MMP2,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP2 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP2 mrna]]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP2 protein]]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP2 mrna],,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
18,1024156,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4313,MMP2,https://ctdbase.org/detail.go?type=gene&acc=4313,,,4313,MMP2,10116,Rattus norvegicus (Norway rat),"Ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of MMP2 protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of MMP2 protein]]",,,PMID:27274199,https://www.ncbi.nlm.nih.gov/pubmed/27274199,27274199,,
19,1024157,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,9606,Homo sapiens (human),[ursolic acid co-treated with oleanolic acid co-treated with irinotecan] results in decreased secretion of and results in decreased expression of MMP9 protein|[ursolic acid co-treated with irinotecan] results in decreased secretion of and results in decreased activity of and results in decreased expression of MMP9 protein|ursolic acid results in decreased secretion of and results in decreased activity of and results in decreased expression of MMP9 protein|[ursolic acid co-treated with oleanolic acid] results in decreased secretion of and results in decreased activity of and results in decreased expression of MMP9 protein,,,PMID:36191607,https://www.ncbi.nlm.nih.gov/pubmed/36191607,36191607,,
20,1024158,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,9606,Homo sapiens (human),Ursolic acid results in decreased expression of MMP9 mRNA,,,PMID:21539908,https://www.ncbi.nlm.nih.gov/pubmed/21539908,21539908,,
21,1024159,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP9 protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP9 mrna]]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP9 protein]]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of MMP9 mrna],,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
22,1024326,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318,MMP9,10116,Rattus norvegicus (Norway rat),"Ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of MMP9 protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in increased expression of MMP9 protein]]",,,PMID:27274199,https://www.ncbi.nlm.nih.gov/pubmed/27274199,27274199,,
23,1024327,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4360,MRC1,https://ctdbase.org/detail.go?type=gene&acc=4360,,,4360,MRC1,10090,Mus musculus (house mouse),[ursolic acid co-treated with IFNG protein co-treated with lipopolysaccharides] results in increased expression of MRC1 mRNA,,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
24,1024328,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,2475,MTOR,https://ctdbase.org/detail.go?type=gene&acc=2475,,,2475,MTOR,9606,Homo sapiens (human),Ursolic acid results in decreased phosphorylation of MTOR protein|ursodoxicoltaurine inhibits the reaction [ursolic acid results in decreased phosphorylation of MTOR protein],,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
25,1024329,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4790,NFKB1,https://ctdbase.org/detail.go?type=gene&acc=4790,,,4790,NFKB1,10090,Mus musculus (house mouse),"[ursolic acid co-treated with glucaric acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with 9,10-dimethyl-1,2-benzanthracene] results in increased expression of NFKB1 protein]",,,PMID:23835587,https://www.ncbi.nlm.nih.gov/pubmed/23835587,23835587,,
26,1024330,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4792,NFKBIA,https://ctdbase.org/detail.go?type=gene&acc=4792,,,4792,NFKBIA,9606,Homo sapiens (human),Ursolic acid analog results in decreased phosphorylation of and results in increased expression of NFKBIA protein,,,PMID:26134000,https://www.ncbi.nlm.nih.gov/pubmed/26134000,26134000,,
27,1024331,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4843,NOS2,https://ctdbase.org/detail.go?type=gene&acc=4843,,,4843,NOS2,10090,Mus musculus (house mouse),Ursolic acid results in decreased expression of NOS2 protein,,,PMID:24051192,https://www.ncbi.nlm.nih.gov/pubmed/24051192,24051192,,
28,1024332,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,4846,NOS3,https://ctdbase.org/detail.go?type=gene&acc=4846,,,4846,NOS3,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [choline results in increased expression of NOS3 protein],,,PMID:27567547,https://www.ncbi.nlm.nih.gov/pubmed/27567547,27567547,,
29,1024333,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,142,PARP1,https://ctdbase.org/detail.go?type=gene&acc=142,,,142,PARP1,9606,Homo sapiens (human),Ursolic acid results in increased cleavage of PARP1 protein,,,PMID:16012738,https://www.ncbi.nlm.nih.gov/pubmed/16012738,16012738,,
30,1024334,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328,PLAU,9606,Homo sapiens (human),[ursolic acid co-treated with oleanolic acid] results in decreased secretion of PLAU protein|[ursolic acid co-treated with irinotecan] results in decreased secretion of PLAU protein|ursolic acid results in decreased secretion of PLAU protein|[ursolic acid co-treated with oleanolic acid co-treated with irinotecan] results in decreased secretion of PLAU protein,,,PMID:36191607,https://www.ncbi.nlm.nih.gov/pubmed/36191607,36191607,,
31,1024479,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5329,PLAUR,https://ctdbase.org/detail.go?type=gene&acc=5329,,,5329,PLAUR,9606,Homo sapiens (human),Ursolic acid results in decreased expression of PLAUR protein|[ursolic acid co-treated with oleanolic acid] results in increased secretion of and results in decreased expression of PLAUR protein|[ursolic acid co-treated with irinotecan] results in increased secretion of and results in decreased expression of PLAUR protein|[ursolic acid co-treated with oleanolic acid co-treated with irinotecan] results in increased secretion of and results in decreased expression of PLAUR protein,,,PMID:36191607,https://www.ncbi.nlm.nih.gov/pubmed/36191607,36191607,,
32,1024480,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of PPARG protein]|2-chloro-5-nitrobenzanilide inhibits the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of PPARG protein]],,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
33,1024481,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5468,PPARG,https://ctdbase.org/detail.go?type=gene&acc=5468,,,5468,PPARG,10116,Rattus norvegicus (Norway rat),"Ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in decreased expression of PPARG protein]|2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in decreased expression of PPARG protein]]",,,PMID:27274199,https://www.ncbi.nlm.nih.gov/pubmed/27274199,27274199,,
34,1024482,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10090,Mus musculus (house mouse),Resveratrol promotes the reaction [ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of ptgs2]]|ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of ptgs2]|ursolic acid promotes the reaction [resveratrol inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of PTGS2]],,,PMID:26100520,https://www.ncbi.nlm.nih.gov/pubmed/26100520,26100520,,
35,1024483,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10090,Mus musculus (house mouse),"[ursolic acid co-treated with glucaric acid] inhibits the reaction [[tetradecanoylphorbol acetate co-treated with 9,10-dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mrna]|ursolic acid inhibits the reaction [[tetradecanoylphorbol acetate co-treated with 9,10-dimethyl-1,2-benzanthracene] results in increased expression of PTGS2 mrna]",,,PMID:23835587,https://www.ncbi.nlm.nih.gov/pubmed/23835587,23835587,,
36,1024484,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743,PTGS2,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of PTGS2 protein]|ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of PTGS2 mrna],,,PMID:26513295,https://www.ncbi.nlm.nih.gov/pubmed/26513295,26513295,,
37,1024485,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [ochratoxin A results in increased expression of BAX protein],,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
38,1024486,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,9606,Homo sapiens (human),Ursolic acid results in increased expression of BAX protein,,,PMID:16012738,https://www.ncbi.nlm.nih.gov/pubmed/16012738,16012738,,
39,1024626,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581,BAX,10090,Mus musculus (house mouse),Ursolic acid results in increased expression of BAX protein,,,PMID:24051192,https://www.ncbi.nlm.nih.gov/pubmed/24051192,24051192,,
40,1024627,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),[ursolic acid results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BECN1 protein]|ursolic acid inhibits the reaction [BCL2 protein binds to BECN1 protein]|ursolic acid results in increased phosphorylation of BCL2 protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
41,1024628,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [ochratoxin A results in decreased expression of BCL2 protein],,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
42,1024629,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),Ursolic acid results in decreased expression of BCL2 mRNA,,,PMID:28868958,https://www.ncbi.nlm.nih.gov/pubmed/28868958,28868958,,
43,1024630,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,596,BCL2,https://ctdbase.org/detail.go?type=gene&acc=596,,,596,BCL2,9606,Homo sapiens (human),Ursolic acid results in decreased expression of BCL2 protein,,,PMID:16012738,https://www.ncbi.nlm.nih.gov/pubmed/16012738,16012738,,
44,1024631,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,8678,BECN1,https://ctdbase.org/detail.go?type=gene&acc=8678,,,8678,BECN1,9606,Homo sapiens (human),[ursolic acid results in increased phosphorylation of BCL2 protein] inhibits the reaction [BCL2 protein binds to BECN1 protein]|ursolic acid inhibits the reaction [BCL2 protein binds to BECN1 protein],,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
45,1024632,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Ursolic acid results in increased cleavage of and results in increased activity of CASP3 protein|acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [ursolic acid results in increased cleavage of and results in increased activity of CASP3 protein],,,PMID:16012738,https://www.ncbi.nlm.nih.gov/pubmed/16012738,16012738,,
46,1024633,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,9606,Homo sapiens (human),Ursolic acid results in increased activity of CASP3 protein,,,PMID:20005942,https://www.ncbi.nlm.nih.gov/pubmed/20005942,20005942,,
47,1024634,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),Ursolic acid results in increased activity of CASP3 protein,,,PMID:19329757,https://www.ncbi.nlm.nih.gov/pubmed/19329757,19329757,,
48,1024635,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,836,CASP3,https://ctdbase.org/detail.go?type=gene&acc=836,,,836,CASP3,10090,Mus musculus (house mouse),Ursolic acid results in increased expression of CASP3 protein,,,PMID:24051192,https://www.ncbi.nlm.nih.gov/pubmed/24051192,24051192,,
49,1024783,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,840,CASP7,https://ctdbase.org/detail.go?type=gene&acc=840,,,840,CASP7,10090,Mus musculus (house mouse),Ursolic acid results in increased activity of CASP7 protein,,,PMID:19329757,https://www.ncbi.nlm.nih.gov/pubmed/19329757,19329757,,
50,1024784,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,841,CASP8,https://ctdbase.org/detail.go?type=gene&acc=841,,,841,CASP8,9606,Homo sapiens (human),Ursolic acid results in increased activity of CASP8 protein,,,PMID:20005942,https://www.ncbi.nlm.nih.gov/pubmed/20005942,20005942,,
51,1024785,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847,CAT,10090,Mus musculus (house mouse),Ursolic acid results in increased activity of CAT protein,,,PMID:24051192,https://www.ncbi.nlm.nih.gov/pubmed/24051192,24051192,,
52,1024786,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595,CCND1,9606,Homo sapiens (human),Ursolic acid results in decreased expression of CCND1 mRNA,,,PMID:24566423,https://www.ncbi.nlm.nih.gov/pubmed/24566423,24566423,,
53,1024787,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,595,CCND1,https://ctdbase.org/detail.go?type=gene&acc=595,,,595,CCND1,9606,Homo sapiens (human),Ursolic acid results in decreased expression of CCND1 protein,,,PMID:24566423|PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24566423|https://www.ncbi.nlm.nih.gov/pubmed/24802810,24566423|24802810,,
54,1024788,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,896,CCND3,https://ctdbase.org/detail.go?type=gene&acc=896,,,896,CCND3,9606,Homo sapiens (human),Ursolic acid results in decreased expression of CCND3 protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
55,1024789,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,898,CCNE1,https://ctdbase.org/detail.go?type=gene&acc=898,,,898,CCNE1,9606,Homo sapiens (human),Ursolic acid results in decreased expression of CCNE1 protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
56,1024790,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,12655,CHIL3,https://ctdbase.org/detail.go?type=gene&acc=12655,,,12655,Chil3,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of CHIL3 mrna]|2-chloro-5-nitrobenzanilide promotes the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of CHIL3 mrna]],,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
57,1024791,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499,CTNNB1,9606,Homo sapiens (human),Ursolic acid results in increased phosphorylation of and results in increased degradation of CTNNB1 protein,,,PMID:24566423,https://www.ncbi.nlm.nih.gov/pubmed/24566423,24566423,,
58,1024792,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,2920,CXCL2,https://ctdbase.org/detail.go?type=gene&acc=2920,,,2920,CXCL2,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of CXCL2 mrna],,,PMID:26513295,https://www.ncbi.nlm.nih.gov/pubmed/26513295,26513295,,
59,1024933,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,54205,CYCS,https://ctdbase.org/detail.go?type=gene&acc=54205,,,54205,CYCS,9606,Homo sapiens (human),Ursolic acid affects the localization of CYCS protein,,,PMID:16012738,https://www.ncbi.nlm.nih.gov/pubmed/16012738,16012738,,
60,1024934,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1557,CYP2C19,https://ctdbase.org/detail.go?type=gene&acc=1557,,,1557,CYP2C19,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [CYP2C19 protein results in increased metabolism of mephenytoin]|ursolic acid results in decreased activity of CYP2C19 protein,,,PMID:15043991,https://www.ncbi.nlm.nih.gov/pubmed/15043991,15043991,,
61,1024935,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [ursolic acid results in increased expression of DDIT3 protein]|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [ursolic acid results in increased expression of DDIT3 protein]|ursodoxicoltaurine inhibits the reaction [ursolic acid results in increased expression of DDIT3 protein]|ursolic acid results in increased expression of DDIT3 protein|eif2ak3 mutant form inhibits the reaction [ursolic acid results in increased expression of DDIT3 protein]",,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
62,1024936,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1649,DDIT3,https://ctdbase.org/detail.go?type=gene&acc=1649,,,1649,DDIT3,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [ochratoxin A promotes the reaction [bardoxolone methyl results in increased expression of DDIT3 protein]]|ursolic acid inhibits the reaction [ochratoxin A results in increased expression of DDIT3 protein],,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
63,1024937,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1906,EDN1,https://ctdbase.org/detail.go?type=gene&acc=1906,,,1906,EDN1,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [choline results in increased expression of EDN1 protein],,,PMID:27567547,https://www.ncbi.nlm.nih.gov/pubmed/27567547,27567547,,
64,1024938,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1956,EGFR,https://ctdbase.org/detail.go?type=gene&acc=1956,,,1956,EGFR,10090,Mus musculus (house mouse),Resveratrol promotes the reaction [ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of egfr]]|ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of egfr]|ursolic acid promotes the reaction [resveratrol inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of EGFR]],,,PMID:26100520,https://www.ncbi.nlm.nih.gov/pubmed/26100520,26100520,,
65,1024939,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,9451,EIF2AK3,https://ctdbase.org/detail.go?type=gene&acc=9451,,,9451,EIF2AK3,9606,Homo sapiens (human),Ursolic acid results in increased phosphorylation of EIF2AK3 protein|eif2ak3 mutant form inhibits the reaction [ursolic acid results in increased phosphorylation of EIF2S1 protein]|ursolic acid inhibits the reaction [HSPA5 protein binds to EIF2AK3 protein]|eif2ak3 mutant form inhibits the reaction [ursolic acid results in increased expression of DDIT3 protein],,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
66,1024940,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,9451,EIF2AK3,https://ctdbase.org/detail.go?type=gene&acc=9451,,,9451,EIF2AK3,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [ochratoxin A results in increased phosphorylation of EIF2AK3 protein],,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
67,1024941,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965,EIF2S1,9606,Homo sapiens (human),Ursolic acid results in increased phosphorylation of EIF2S1 protein|ursodoxicoltaurine inhibits the reaction [ursolic acid results in increased phosphorylation of EIF2S1 protein]|eif2ak3 mutant form inhibits the reaction [ursolic acid results in increased phosphorylation of EIF2S1 protein],,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
68,1025116,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1965,EIF2S1,https://ctdbase.org/detail.go?type=gene&acc=1965,,,1965,EIF2S1,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [ochratoxin A results in increased phosphorylation of EIF2S1 protein],,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
69,1025117,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,1978,EIF4EBP1,https://ctdbase.org/detail.go?type=gene&acc=1978,,,1978,EIF4EBP1,9606,Homo sapiens (human),Ursolic acid results in decreased expression of EIF4EBP1 protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
70,1025118,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,2081,ERN1,https://ctdbase.org/detail.go?type=gene&acc=2081,,,2081,ERN1,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [ochratoxin A results in increased expression of ERN1 protein],,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
71,1025119,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,2081,ERN1,https://ctdbase.org/detail.go?type=gene&acc=2081,,,2081,ERN1,9606,Homo sapiens (human),Ursolic acid results in increased activity of ERN1 protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
72,1025120,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,2213,FCGR2B,https://ctdbase.org/detail.go?type=gene&acc=2213,,,2213,FCGR2B,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of FCGR2B mrna],,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
73,1025121,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,14131,FCGR3,https://ctdbase.org/detail.go?type=gene&acc=14131,,,14131,Fcgr3,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in increased expression of FCGR3 mrna],,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
74,1025122,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,2875,GPT,https://ctdbase.org/detail.go?type=gene&acc=2875,,,2875,GPT,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [choline results in increased activity of GPT protein],,,PMID:27567547,https://www.ncbi.nlm.nih.gov/pubmed/27567547,27567547,,
75,1025123,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309,HSPA5,9606,Homo sapiens (human),"Acetylcysteine inhibits the reaction [ursolic acid results in increased expression of HSPA5 protein]|ursolic acid results in increased expression of HSPA5 protein|1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [ursolic acid results in increased expression of HSPA5 protein]|ursolic acid inhibits the reaction [HSPA5 protein binds to EIF2AK3 protein]|ursodoxicoltaurine inhibits the reaction [ursolic acid results in increased expression of HSPA5 protein]",,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
76,1025124,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3309,HSPA5,https://ctdbase.org/detail.go?type=gene&acc=3309,,,3309,HSPA5,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [ochratoxin A results in increased expression of HSPA5 protein],,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
77,1025125,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383,ICAM1,9606,Homo sapiens (human),Ursolic acid results in decreased expression of ICAM1 mRNA,,,PMID:21539908,https://www.ncbi.nlm.nih.gov/pubmed/21539908,21539908,,
78,1025267,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383,ICAM1,9606,Homo sapiens (human),Ursolic acid results in decreased expression of ICAM1 protein,,,PMID:20005942,https://www.ncbi.nlm.nih.gov/pubmed/20005942,20005942,,
79,1025268,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5770,PTPN1,https://ctdbase.org/detail.go?type=gene&acc=5770,,,5770,PTPN1,9606,Homo sapiens (human),Ursolic acid results in decreased activity of PTPN1 protein,,,PMID:27085377|PMID:29175190|PMID:30160205|PMID:36933777,https://www.ncbi.nlm.nih.gov/pubmed/27085377|https://www.ncbi.nlm.nih.gov/pubmed/29175190|https://www.ncbi.nlm.nih.gov/pubmed/30160205|https://www.ncbi.nlm.nih.gov/pubmed/36933777,27085377|29175190|30160205|36933777,,
80,1025269,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5970,RELA,https://ctdbase.org/detail.go?type=gene&acc=5970,,,5970,RELA,9606,Homo sapiens (human),Ursolic acid analog results in decreased expression of RELA mrna|ursolic acid analog results in decreased expression of RELA protein,,,PMID:26134000,https://www.ncbi.nlm.nih.gov/pubmed/26134000,26134000,,
81,1025270,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,6198,RPS6KB1,https://ctdbase.org/detail.go?type=gene&acc=6198,,,6198,RPS6KB1,9606,Homo sapiens (human),Ursolic acid results in decreased expression of RPS6KB1 protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
82,1025271,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,175925,RPT-3,https://ctdbase.org/detail.go?type=gene&acc=175925,,,175925,rpt-3,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [APP protein modified form results in decreased expression of RPT-3 protein],,,PMID:34902447,https://www.ncbi.nlm.nih.gov/pubmed/34902447,34902447,,
83,1025272,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,10280,SIGMAR1,https://ctdbase.org/detail.go?type=gene&acc=10280,,,10280,SIGMAR1,9606,Homo sapiens (human),Ursolic acid results in increased expression of SIGMAR1 protein|ursolic acid inhibits the reaction [bardoxolone methyl results in decreased expression of SIGMAR1 protein]|ursolic acid inhibits the reaction [ochratoxin A results in decreased expression of SIGMAR1 protein],,,PMID:36587836,https://www.ncbi.nlm.nih.gov/pubmed/36587836,36587836,,
84,1025273,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,6714,SRC,https://ctdbase.org/detail.go?type=gene&acc=6714,,,6714,SRC,10090,Mus musculus (house mouse),Ursolic acid promotes the reaction [resveratrol inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of src]]|ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of src]|resveratrol promotes the reaction [ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of SRC]],,,PMID:26100520,https://www.ncbi.nlm.nih.gov/pubmed/26100520,26100520,,
85,1025274,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,6774,STAT3,https://ctdbase.org/detail.go?type=gene&acc=6774,,,6774,STAT3,10090,Mus musculus (house mouse),Resveratrol promotes the reaction [ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of stat3]]|ursolic acid promotes the reaction [resveratrol inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of stat3]]|ursolic acid inhibits the reaction [tetradecanoylphorbol acetate results in increased expression of STAT3],,,PMID:26100520,https://www.ncbi.nlm.nih.gov/pubmed/26100520,26100520,,
86,1025275,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,7040,TGFB1,https://ctdbase.org/detail.go?type=gene&acc=7040,,,7040,TGFB1,9606,Homo sapiens (human),Ursolic acid results in decreased expression of TGFB1 protein,,,PMID:21539908,https://www.ncbi.nlm.nih.gov/pubmed/21539908,21539908,,
87,1025404,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076,TIMP1,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of TIMP1 protein]|2-chloro-5-nitrobenzanilide promotes the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of TIMP1 protein]]|2-chloro-5-nitrobenzanilide promotes the reaction [ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of TIMP1 mrna]]|ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of TIMP1 mrna],,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
88,1025405,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,7076,TIMP1,https://ctdbase.org/detail.go?type=gene&acc=7076,,,7076,TIMP1,10116,Rattus norvegicus (Norway rat),"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in decreased expression of TIMP1 protein]]|ursolic acid inhibits the reaction [[oxygen deficiency co-treated with blood glucose deficiency] results in decreased expression of TIMP1 protein]",,,PMID:27274199,https://www.ncbi.nlm.nih.gov/pubmed/27274199,27274199,,
89,1025406,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124,TNF,10090,Mus musculus (house mouse),Ursolic acid results in decreased expression of TNF protein,,,PMID:24051192,https://www.ncbi.nlm.nih.gov/pubmed/24051192,24051192,,
90,1025407,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,7150,TOP1,https://ctdbase.org/detail.go?type=gene&acc=7150,,,7150,TOP1,9606,Homo sapiens (human),Ursolic acid results in decreased activity of TOP1 protein,,,PMID:10860928,https://www.ncbi.nlm.nih.gov/pubmed/10860928,10860928,,
91,1025408,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,7153,TOP2A,https://ctdbase.org/detail.go?type=gene&acc=7153,,,7153,TOP2A,9606,Homo sapiens (human),Ursolic acid results in decreased activity of TOP2A protein,,,PMID:10860928,https://www.ncbi.nlm.nih.gov/pubmed/10860928,10860928,,
92,1025409,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,7422,VEGFA,https://ctdbase.org/detail.go?type=gene&acc=7422,,,7422,VEGFA,10090,Mus musculus (house mouse),Ursolic acid results in decreased expression of VEGFA protein,,,PMID:24051192,https://www.ncbi.nlm.nih.gov/pubmed/24051192,24051192,,
93,1025410,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,PTGS1,https://www.dgidb.org/genes/PTGS1,,,5742,PTGS1,9606,Homo sapiens (human),,,,PMID:9784154,https://www.ncbi.nlm.nih.gov/pubmed/9784154,9784154,,
94,1025411,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,PTPN1,https://www.dgidb.org/genes/PTPN1,,,5770,PTPN1,9606,Homo sapiens (human),,,,PMID:21453996,https://www.ncbi.nlm.nih.gov/pubmed/21453996,21453996,,
95,1090949,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,PPARA,https://www.dgidb.org/genes/PPARA,,,5465,PPARA,9606,Homo sapiens (human),,,,PMID:21855333,https://www.ncbi.nlm.nih.gov/pubmed/21855333,21855333,,
96,1108061,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,HSD11B1,https://www.dgidb.org/genes/HSD11B1,,,3290,HSD11B1,9606,Homo sapiens (human),,,,PMID:20100662,https://www.ncbi.nlm.nih.gov/pubmed/20100662,20100662,,
97,1139594,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,5243,ABCB1,https://ctdbase.org/detail.go?type=gene&acc=5243,,,5243,ABCB1,9606,Homo sapiens (human),Ursolic acid results in decreased expression of ABCB1 mrna|ursolic acid results in decreased expression of ABCB1 protein|abcb1 protein inhibits the reaction [ursolic acid results in increased susceptibility to doxorubicin],,,PMID:33009882,https://www.ncbi.nlm.nih.gov/pubmed/33009882,33009882,,
98,1139595,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,31,ACACA,https://ctdbase.org/detail.go?type=gene&acc=31,,,31,ACACA,9606,Homo sapiens (human),Ursolic acid results in increased phosphorylation of ACACA protein,,,PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/24802810,24802810,,
99,1139596,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,9131,AIFM1,https://ctdbase.org/detail.go?type=gene&acc=9131,,,9131,AIFM1,9606,Homo sapiens (human),AIFM1 mutant form results in decreased susceptibility to ursolic acid|ursolic acid results in increased localization of AIFM1 protein,,,PMID:20630652,https://www.ncbi.nlm.nih.gov/pubmed/20630652,20630652,,
100,1139597,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207,AKT1,9606,Homo sapiens (human),Ursolic acid results in decreased phosphorylation of AKT1 protein,,,PMID:19344998|PMID:24802810,https://www.ncbi.nlm.nih.gov/pubmed/19344998|https://www.ncbi.nlm.nih.gov/pubmed/24802810,19344998|24802810,,
101,1139598,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351,APP,9606,Homo sapiens (human),Ursolic acid inhibits the reaction [APP protein modified form results in decreased expression of RPT-3 protein]|ursolic acid inhibits the reaction [APP protein modified form results in increased susceptibility to serotonin],,,PMID:34902447,https://www.ncbi.nlm.nih.gov/pubmed/34902447,34902447,,
102,1139599,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,383,ARG1,https://ctdbase.org/detail.go?type=gene&acc=383,,,383,ARG1,10090,Mus musculus (house mouse),Ursolic acid inhibits the reaction [[IFNG protein co-treated with lipopolysaccharides] results in decreased expression of ARG1 mrna],,,PMID:37019307,https://www.ncbi.nlm.nih.gov/pubmed/37019307,37019307,,
103,1139600,64945,Comparative Toxicogenomics Database (CTD),Ursolic Acid,C005466,ursolic acid,https://ctdbase.org/detail.go?type=chem&acc=C005466,578,BAK1,https://ctdbase.org/detail.go?type=gene&acc=578,,,578,BAK1,9606,Homo sapiens (human),Ursolic acid results in increased activity of BAK1 protein,,,PMID:20630652,https://www.ncbi.nlm.nih.gov/pubmed/20630652,20630652,,
104,1145583,64945,Therapeutic Target Database (TTD),Ursolic Acid,D07LUJ,URSOLIC ACID,https://idrblab.net/ttd/data/drug/details/D07LUJ,T65200,Corticosteroid 11-beta-dehydrogenase 1 (HSD11B1),https://idrblab.net/ttd/data/target/details/T65200,P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,3290,HSD11B1,9606,Homo sapiens (human),Inhibitor,,,,,,,
105,1145584,64945,Therapeutic Target Database (TTD),Ursolic Acid,D07LUJ,URSOLIC ACID,https://idrblab.net/ttd/data/drug/details/D07LUJ,T31479,Phospholipase A2 (PLA2G1B),https://idrblab.net/ttd/data/target/details/T31479,P04054,Phospholipase A2,5319,PLA2G1B,9606,Homo sapiens (human),Inhibitor,,,,,,,
106,1145585,64945,Therapeutic Target Database (TTD),Ursolic Acid,D07LUJ,URSOLIC ACID,https://idrblab.net/ttd/data/drug/details/D07LUJ,T37847,Herpes simplex virus DNA polymerase UL30 (HSV UL30),https://idrblab.net/ttd/data/target/details/T37847,P04293,DNA polymerase catalytic subunit,2703462,UL30,10299,Human alphaherpesvirus 1 strain 17,Inhibitor,,,,,,,
107,1145586,64945,Therapeutic Target Database (TTD),Ursolic Acid,D07LUJ,URSOLIC ACID,https://idrblab.net/ttd/data/drug/details/D07LUJ,T98062,Glycogen phosphorylase muscle form (GP),https://idrblab.net/ttd/data/target/details/T98062,P11217,"Glycogen phosphorylase, muscle form",5837,PYGM,9606,Homo sapiens (human),Inhibitor,,,,,,,
108,1145587,64945,Therapeutic Target Database (TTD),Ursolic Acid,D07LUJ,URSOLIC ACID,https://idrblab.net/ttd/data/drug/details/D07LUJ,T89529,PTPN1 messenger RNA (PTPN1 mRNA),https://idrblab.net/ttd/data/target/details/T89529,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770,PTPN1,9606,Homo sapiens (human),Inhibitor,,,,,,,
109,1179468,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,HDAC1,https://www.dgidb.org/genes/HDAC1,,,3065,HDAC1,9606,Homo sapiens (human),,,,PMID:19534471,https://www.ncbi.nlm.nih.gov/pubmed/19534471,19534471,,
110,1179469,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,HDAC3,https://www.dgidb.org/genes/HDAC3,,,8841,HDAC3,9606,Homo sapiens (human),,,,PMID:19534471,https://www.ncbi.nlm.nih.gov/pubmed/19534471,19534471,,
111,1179470,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,PTGS2,https://www.dgidb.org/genes/PTGS2,,,5743,PTGS2,9606,Homo sapiens (human),,,,PMID:9784154,https://www.ncbi.nlm.nih.gov/pubmed/9784154,9784154,,
112,1240688,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,HDAC6,https://www.dgidb.org/genes/HDAC6,,,10013,HDAC6,9606,Homo sapiens (human),,,,PMID:19534471,https://www.ncbi.nlm.nih.gov/pubmed/19534471,19534471,,
113,1832889,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,GSK3B,https://www.dgidb.org/genes/GSK3B,,,2932,GSK3B,9606,Homo sapiens (human),,,,PMID:19716700,https://www.ncbi.nlm.nih.gov/pubmed/19716700,19716700,,
114,1852679,64945,BindingDB,Ursolic Acid,50148911,(3beta)-3-hydroxyurs-12-en-28-oic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50148911,5023,Leukocyte elastase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5023,P08246,Neutrophil elastase,1991,ELANE,9606,Homo sapiens (human),,IC50 (nM),416.0,PMID:22803662,https://www.ncbi.nlm.nih.gov/pubmed/22803662,22803662,,
115,1871865,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,AKR1B10,https://www.dgidb.org/genes/AKR1B10,,,57016,AKR1B10,9606,Homo sapiens (human),,,,PMID:21561086,https://www.ncbi.nlm.nih.gov/pubmed/21561086,21561086,,
116,1928792,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,HDAC4,https://www.dgidb.org/genes/HDAC4,,,9759,HDAC4,9606,Homo sapiens (human),,,,PMID:19534471,https://www.ncbi.nlm.nih.gov/pubmed/19534471,19534471,,
117,1928793,64945,BindingDB,Ursolic Acid,50148911,(3beta)-3-hydroxyurs-12-en-28-oic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50148911,2622,Protein-tyrosine phosphatase 1B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2622,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770,PTPN1,9606,Homo sapiens (human),,IC50 (nM),9430.0,,,,,
118,1928833,64945,BindingDB,Ursolic Acid,50148911,(3beta)-3-hydroxyurs-12-en-28-oic acid,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50148911,2622,Protein-tyrosine phosphatase 1B,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=2622,P18031,Tyrosine-protein phosphatase non-receptor type 1,5770,PTPN1,9606,Homo sapiens (human),,IC50 (nM),4500.0,,,,,
119,1966167,64945,Drug Gene Interaction database (DGIdb),Ursolic Acid,,URSOLIC ACID,https://www.dgidb.org/drugs/URSOLIC ACID,,HDAC5,https://www.dgidb.org/genes/HDAC5,,,10014,HDAC5,9606,Homo sapiens (human),,,,PMID:19534471,https://www.ncbi.nlm.nih.gov/pubmed/19534471,19534471,,
